Prostanozol
Chemical compound
Prostanozol | |
---|---|
![]() | |
INN | |
Drug class | Androgen; Anabolic steroid; Androgen ether |
Routes of administration | By mouth |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | 1186001-41-1 |
PubChem | 56842253 |
DrugBank | |
ChemSpider | 32700007 |
KEGG |
Prostanozol is a steroid that was first synthesized in the 1970s by Syntex, a multinational pharmaceutical company. It is a derivative of dihydrotestosterone (DHT), a naturally occurring hormone in the human body. Prostanozol is classified as an anabolic steroid, which means it promotes muscle growth.
History
Prostanozol was first synthesized in the 1970s by Syntex, a pharmaceutical company that was also responsible for the creation of other notable steroids such as Oxymetholone and Methandrostenolone. Despite its synthesis, Prostanozol was never marketed by Syntex and remained relatively unknown until the early 2000s.
Pharmacology
As a derivative of DHT, Prostanozol shares many of the same properties. It is an anabolic steroid, which means it promotes the growth of muscle tissue. However, unlike many other anabolic steroids, Prostanozol does not convert into estrogen in the body, which can lead to side effects such as water retention and gynecomastia.
Legal Status
In many countries, including the United States, Prostanozol is classified as a controlled substance. This means it is illegal to possess, use, or distribute without a prescription or license. In the world of professional sports, Prostanozol is banned by most major athletic organizations due to its performance-enhancing effects.
Side Effects
Like all anabolic steroids, Prostanozol can have serious side effects. These can include liver damage, cardiovascular issues, changes in mood and behavior, and in men, shrinkage of the testicles and development of breast tissue. Long-term use can also lead to dependency and withdrawal symptoms.
See Also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD